The cheapest semaglutide online, by monthly budget.
Semaglutide is the molecule in Ozempic and Wegovy. This board lists the 25 lowest compounded semaglutide recurring prices without a prepaid multi-month term, each read from the provider's own site.
HSA / FSA-eligible
Six-factor Metabolic-Fit Score
Prices verified October 2026
The short answer
The lowest average monthly budget is $79/month on average (CoreAge Rx); the 25 cheapest run to $129. First-month teasers, prepaid plans and fee-only rows are left out. CoreAge Rx is a featured partner; providers we work with may appear first, and every row prints its actual charge and billing unit. Weekly cycles are converted using 52 weeks ÷ 12 months for comparison.
Cheapest compounded semaglutide, by average monthly budget
25 of 189 providers. CoreAge Rx is a featured partner; providers we work with may appear first. The Metabolic-Fit Score is printed on every row so you can check it.
CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
A low-entry, all-in compounded program with both molecules, one price at every dose and a clean cancel-anytime policy — appealing, though the 'from' price isn't explained and the outcome claims are unverified marketing.
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month and the same price at every dose, plus a separate microdose line for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prepaying for a year brings it to $89 and $139 a month, and the first-order discount of up to $140 is promotional.
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month, one price at every dose that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. The $69 and $119 on its homepage are the 12-month prepay rates, billed once up front with no refund for unused months, and they sit under a live countdown clock with a lock-for-life promise that is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
Its recorded operator, Trinity HealthCare Supply LLC dba altRx, received FDA warning letter 728236 concerning another website. NextMeds’ current catalog lists semaglutide at $79 a month and tirzepatide at $129, with the same renewal prices. Its $49 headline requires the $588 annual semaglutide plan.
Semaglutide: From $79.99/mo; tirzepatide: From $149.99/mo. These are advertised starting amounts; dose, plan duration and renewal conditions need confirmation.
Eighty-six dollars a month for compounded semaglutide is among the lowest figures on this page, and $125 for tirzepatide is genuinely cheap for the dual agonist. What sits directly beneath those numbers is the problem. Each card carries an average: "Average 15-20% body weight loss" on the semaglutide, "Average 20-25%" on the tirzepatide. The upper end of that second range is higher than tirzepatide achieved at its maximum dose in its own registrational trial, and these are compounded products that were never in one.
Mondae lists semaglutide at $87 a month and tirzepatide at $126 with a one-month plan. Its lower $69 and $114 averages require six-month prepayments of $414 and $684.
One of the lowest listed prices for compounded GLP-1s — $89 a month for semaglutide and $149 for tirzepatide, the same at every dose, with the visit, supplies and shipping included — from a company that received an FDA warning letter in June 2026 and treats every payment as final. Cancellation needs 72 hours' notice, and a documented trinitymeds trademark connection deserves attention.
LumiMeds carries a 2025 FDA warning letter over how it described its compounded medication. Semaglutide: $89/mo advertised flat rate; tirzepatide: $125/mo advertised flat rate. The promotion promises a price lock, but terms reserve price changes, restrict mid-term cancellation and apply a $100 deduction to applicable refunds.
Advertised dose-flat monthly plans are $99 for semaglutide and $149 for tirzepatide, with care, medication and shipping included. Confirm the selected supply and plan. Cancellation stops future renewal; after prescribing, payments including unused prepaid months are nonrefundable under the stated policy.
Pepti publishes semaglutide prices of $99–$199 a month and tirzepatide prices of $159–$319, depending on dose. Medication, physician care and shipping are included without a separate membership fee.
Teleios advertises either compounded semaglutide or tirzepatide from $99 monthly, including medication, consultations and shipping. Care runs through the named Lion MD network, and state-specific availability needs confirmation.
Livea is one of the few names here with a history that predates the GLP-1 boom — it operates as Livea Medical, PLLC under Minnesota Weight Control, Inc., a weight-management business rather than a telehealth startup. Compounded semaglutide starts at $99 a month and tirzepatide at $199 "when available", a qualification most sellers leave out. It also does something unusual in its own FAQ: it puts its price next to the brand-name alternative, "compared to $1,000+ per month for brand-name Ozempic or Wegovy".
One of the few genuinely flat prices on this list — $99/mo semaglutide and $134/mo tirzepatide that do not rise as your dose does, in all fifty states — from a company that never names itself anywhere on its own website.
Magnolia advertises semaglutide with B12 from $99/month and tirzepatide with B12 from $179, with monthly and quarterly options. Its telehealth list names 25 states plus DC, and it also operates Louisiana clinics; labs cost extra and cancellation requires written notice at least 24 hours before monthly renewal.
Its pricing table is headed "Transparent Monthly Pricing", but the figures are count-up animations that start at $0.00, and the version search engines and screen readers get shows the semaglutide program at $0.00 and tirzepatide at $195.82 — neither matches the $114.99 and $191.99 a visitor finally sees.
Trava product pages list semaglutide from $117.96 monthly and tirzepatide from $178.98 monthly. Cheaper homepage figures coexist with the product rates; quarterly savings of about $88 and $95 are package totals, not discounts every month.
"As low as $83/mo, all-in" is $999 paid up front, divided by twelve. Month to month is $119. The honest thing to say next is that $119 is still cheaper than most providers we review, so the problem is the advertised number rather than the price behind it.
Sumbare's pitch is warmth — "a team that celebrates every body" — and one price, "Plans from $120/mo · confirmed after provider review", with nothing broken out by drug or dose. The claim that needs checking is the one under its progress chart: "~15–20% avg. body-weight change", sourced to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". Those trials do not exist. Compounded medicines are not FDA-approved and are not put through registrational trials; those figures come from studies of the branded drugs.
A flat-priced provider naming several individual physicians (including a specifically-credited Medical Director) — $125/mo semaglutide, $145/mo tirzepatide as currently displayed — though the site's own strikethrough pricing presentation leaves it unresolved whether that's a standing rate or a promotional one, so confirm at signup.
Semaglutide: $126/mo monthly; $107.10/mo quarterly; tirzepatide: $144/mo monthly; $122.40/mo quarterly. Quarterly totals are $321.30 and $367.20; advertised prices include the listed care and shipping fees and exclude California.
Semaglutide: $129/mo monthly ($99/mo on a 3-month pack); tirzepatide: $149/mo monthly ($119/mo on a 3-month pack). Three-month packs cost $297 for semaglutide or $357 for tirzepatide upfront, with transfer patients advised to confirm eligibility and pricing.
Of the 189 providers that publish a recurring compounded semaglutide price, the lowest average monthly budget is $79 (CoreAge Rx). On that monthly-average basis, the 25 lowest run from $79 to $129, and half sit at or under $99. Check the price at your maintenance dose before you pay.
How does that compare with brand Wegovy?+
Novo Nordisk's NovoCare Pharmacy lists self-pay Wegovy pens at $349 a month for every dose from 0.25 mg to 2.4 mg, and new patients pay $199 for each of their first two monthly fills at 0.25 mg and 0.5 mg through December 31, 2026. Wegovy 7.2 mg is $399 a month, and the Wegovy pill starts at $149. Brand Wegovy is FDA-approved; compounded semaglutide is not, which is the main reason it costs less.
Is compounded semaglutide the same as Ozempic or Wegovy?+
It is the same molecule, but it is not the same product. A compounded version is prepared by a pharmacy, is not reviewed by the FDA for safety or quality, and may be a different salt or carry an added ingredient. Ask which licensed U.S. pharmacy fills yours.
Can I use semaglutide while breastfeeding?+
For the Ozempic and Wegovy injections, the labels say there are no data on a breastfed infant and ask you and your clinician to weigh the benefits of breastfeeding against your need for the drug. The Wegovy pill and Rybelsus labels say breastfeeding is not recommended. Semaglutide is not used in pregnancy, and the labels advise stopping at least two months before a planned pregnancy.
Rankings reflect our published methodology. This page is informational and not medical advice; compounded medications are not FDA-approved brand products, and GLP-1 medicines are not used in pregnancy or while trying to conceive. See our medical disclaimer. Some links here earn us a referral fee, walled off from the score — read our funding disclosure.
Keep exploring
Other ranked boards for mothers
Each board answers a different question a mother brings to GLP-1 care.